We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MT:EURONEXT AMSTERDAMArcelorMittal SA Analysis

Data as of 2026-08-30 - not real-time

$74.39

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

ArcelorMittal S.A. is priced at $74.39 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 11.9%. Momentum indicators put RSI at 59.1 (neutral) with MACD reading bearish. Watch $69.29 as support and $75.93 as the nearer resistance level.
Multiples put this in fair territory at a P/E of 31.4. Revenue is growing at 5.2% on a 2.9% profit margin. The 0.80% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 32.7%, a beta of 2.09 and a maximum drawdown of 28.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.

Top Market Events

31 July 2026, 20:30 CET ArcelorMittal has today published its half-year report for the six-month period ended 30 June...ArcelorMittal stock reacts to fresh analyst coverage on August 24, 2026, with a new Overweight ratinYahoo Finance1monArcelorMittal SA MT Q2 2026 Earnings Call Highlights: Strong EBITDA and Counter-Seasonal .

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 58.46
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 58.46
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative free cash flow
  • P/E ratio of 31.4
  • Dividend yield of 0.80%

Key Metrics & Analysis

Financial Health

Revenue Growth5.20%
Profit Margin2.88%
P/E Ratio31.4
ROE3.28%
ROA1.63%
Debt/Equity25.38
P/B Ratio2.0
Op. Cash Flow$4.7B
Free Cash Flow$-779124992

Technical Analysis

TrendBullish
RSI59.1
Support$69.29
Resistance$75.93
MA 20$73.56
MA 50$68.23
MA 200$58.46
MACDBearish
VolumeIncreasing
Fear & Greed Index95.66

Valuation

Fair Value$57.22
Target Price$76.20
Upside/Downside2.43%
GradeFair
TypeGrowth
Dividend Yield0.80%

Risk Assessment

Beta2.09
Volatility32.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.